rs202051419
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_001378609.3(OTOGL):c.3020T>C(p.Val1007Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000147 in 1,550,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.3020T>C | p.Val1007Ala | missense_variant | Exon 27 of 59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.3020T>C | p.Val1007Ala | missense_variant | Exon 27 of 59 | 5 | NM_001378609.3 | ENSP00000447211.2 | ||
OTOGL | ENST00000646859.1 | c.2929-5716T>C | intron_variant | Intron 31 of 62 | ENSP00000496036.1 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000184 AC: 32AN: 173514Hom.: 0 AF XY: 0.000183 AC XY: 17AN XY: 92892
GnomAD4 exome AF: 0.0000865 AC: 121AN: 1398546Hom.: 0 Cov.: 30 AF XY: 0.0000853 AC XY: 59AN XY: 691938
GnomAD4 genome AF: 0.000702 AC: 107AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000644 AC XY: 48AN XY: 74490
ClinVar
Submissions by phenotype
not specified Benign:1
p.Val998Ala in exon 26 of OTOGL: This variant is not expected to have clinical s ignificance because it has been identified in 0.4% (11/2572) of African chromoso mes by the xome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs202051419). -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at